PharmaTimesNews & Politicsnews

Poolbeg secures Canadian patent for POLB 001 in cancer immunotherapy‑induced CRS

Monday, May 11, 2026John PinchingView original

Second national grant strengthens company’s expanding global IP estate

Read the full article on the original site.

Read Full Article